As of 4:00pm ET
| +0.25 / +1.33%|
The 13 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 18.00, with a high estimate of 39.00 and a low estimate of 14.00. The median estimate represents a -5.51% decrease from the last price of 19.05.
The current consensus among 18 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.